Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments.
Seed funding for novel, high-risk, high-reward translational research projects on neurodegenerative diseases of aging. Preliminary data is not required.
Applications in this round must relate to one of the following disease(s): PD, PSP, DLB, MSA, prodromes and/or vascular contributions to these diseases.
Project Eligibility: Project must involve the development of either a therapeutic, a tool, select complementary approaches, or a combination of above to help accelerate the development of therapeutics for neurodegenerative diseases of aging.
NEW for 2018/2019:
We encourage applications that bring in expertise, technologies or approaches in the following areas to advance the development of therapeutics and tools for neurodegenerative diseases of aging: artificial intelligence, big data, machine learning, data science, computer science, medicinal chemistry, biostatistics and engineering. Read more.
Weston Brain Institute
Funding Available: Up to $200,000 over up to 18 months.
Wednesday, August 1, 2018